Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liza C Villaruz

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 15, 2016
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yesLiza C Villaruz, Mark A Socinski
Lung Cancer (Amsterdam, Netherlands)|December 24, 2013
Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutationLiza C Villaruz, Mark A Socinski
Seminars in Thoracic and Cardiovascular Surgery|March 27, 2012
Personalized therapy for non-small cell lung cancer: which drug for which patient?Liza C Villaruz, Mark A Socinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
The clinical viewpoint: definitions, limitations of RECIST, practical considerations of measurementLiza C Villaruz, Mark A Socinski
Current Oncology Reports|May 8, 2015
The role of anti-angiogenesis in non-small-cell lung cancer: an updateLiza C Villaruz, Mark A Socinski
The Oncologist|November 9, 2016
Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at ProgressionMark A Socinski, Liza C Villaruz, Jeffrey Ross
Drugs|May 22, 2020
Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung CancerAshwin Somasundaram, Mark A Socinski, Liza C Villaruz
Frontiers in Oncology|April 20, 2023
Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicineLiza C Villaruz, Mark A Socinski, Jared Weiss
Discovery Medicine|September 2, 2016
Immune checkpoint blockade in lung cancerAswin Somasundaram, Mark A Socinski, Liza C Villaruz
Current Oncology Reports|April 27, 2012
Management of non-small cell lung cancer with oligometastasisLiza C Villaruz, Gregory J Kubicek, Mark A Socinski
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|February 15, 2016
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yesLiza C Villaruz, Mark A Socinski
Lung Cancer (Amsterdam, Netherlands)|December 24, 2013
Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutationLiza C Villaruz, Mark A Socinski
Seminars in Thoracic and Cardiovascular Surgery|March 27, 2012
Personalized therapy for non-small cell lung cancer: which drug for which patient?Liza C Villaruz, Mark A Socinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
The clinical viewpoint: definitions, limitations of RECIST, practical considerations of measurementLiza C Villaruz, Mark A Socinski
Current Oncology Reports|May 8, 2015
The role of anti-angiogenesis in non-small-cell lung cancer: an updateLiza C Villaruz, Mark A Socinski
The Oncologist|November 9, 2016
Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at ProgressionMark A Socinski, Liza C Villaruz, Jeffrey Ross
Drugs|May 22, 2020
Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung CancerAshwin Somasundaram, Mark A Socinski, Liza C Villaruz
Frontiers in Oncology|April 20, 2023
Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicineLiza C Villaruz, Mark A Socinski, Jared Weiss
Discovery Medicine|September 2, 2016
Immune checkpoint blockade in lung cancerAswin Somasundaram, Mark A Socinski, Liza C Villaruz
Current Oncology Reports|April 27, 2012
Management of non-small cell lung cancer with oligometastasisLiza C Villaruz, Gregory J Kubicek, Mark A Socinski
Pageof 6